Raymond J Davey1, Timothy W Jones, Paul A Fournier. 1. School of Sport Science, Exercise and Health, University of Western Australia, Crawley, Western Australia, Australia. daveyr01@student.uwa.edu.au
Abstract
BACKGROUND: The objective of this study was to examine whether setting the low glucose alarm of a Guardian® REAL-Time continuous glucose monitoring system (CGMS) to 80 mg/dl for 3 days and providing instructions to users reduce the risk of hypoglycemia under free-living conditions in individuals with type 1 diabetes mellitus (T1DM). METHODS:Fourteen participants with T1DM aged 26.1±6.0 years (mean±standard deviation) were fitted with a CGMS and assigned for 3 days to either an alarm [low and high blood glucose (BG) alarms set at 80 and 200 mg/dl, respectively] or no alarm condition, with each treatment administered to all participants following a counterbalanced design. All participants were given detailed instructions on how to respond appropriately to low glucose alarms. RESULTS: The CGMS with alarm reduced the incidence of hypoglycemia (CGMS readings≤65 mg/dl) by 44% as well as the time spent below this hypoglycemic threshold by 64% without increasing average BG levels. However, the CGMS with alarm had no effect on the incidence of symptomatic hypoglycemia. CONCLUSIONS: Short-term use of the CGMS with alarm, together with appropriate instructions for users, reduces the incidence and duration of hypoglycemia, but only to a limited extent, in part because it overestimates BG in the low glucose range.
RCT Entities:
BACKGROUND: The objective of this study was to examine whether setting the low glucose alarm of a Guardian® REAL-Time continuous glucose monitoring system (CGMS) to 80 mg/dl for 3 days and providing instructions to users reduce the risk of hypoglycemia under free-living conditions in individuals with type 1 diabetes mellitus (T1DM). METHODS: Fourteen participants with T1DM aged 26.1±6.0 years (mean±standard deviation) were fitted with a CGMS and assigned for 3 days to either an alarm [low and high blood glucose (BG) alarms set at 80 and 200 mg/dl, respectively] or no alarm condition, with each treatment administered to all participants following a counterbalanced design. All participants were given detailed instructions on how to respond appropriately to low glucose alarms. RESULTS: The CGMS with alarm reduced the incidence of hypoglycemia (CGMS readings≤65 mg/dl) by 44% as well as the time spent below this hypoglycemic threshold by 64% without increasing average BG levels. However, the CGMS with alarm had no effect on the incidence of symptomatic hypoglycemia. CONCLUSIONS: Short-term use of the CGMS with alarm, together with appropriate instructions for users, reduces the incidence and duration of hypoglycemia, but only to a limited extent, in part because it overestimates BG in the low glucose range.
Authors: Iris M Wentholt; Marit A Vollebregt; Augustus A Hart; Joost B Hoekstra; J Hans DeVries Journal: Diabetes Care Date: 2005-12 Impact factor: 19.112
Authors: Darrell M Wilson; Roy W Beck; William V Tamborlane; Mariya J Dontchev; Craig Kollman; Peter Chase; Larry A Fox; Katrina J Ruedy; Eva Tsalikian; Stuart A Weinzimer Journal: Diabetes Care Date: 2007-01 Impact factor: 19.112
Authors: William V Tamborlane; Roy W Beck; Bruce W Bode; Bruce Buckingham; H Peter Chase; Robert Clemons; Rosanna Fiallo-Scharer; Larry A Fox; Lisa K Gilliam; Irl B Hirsch; Elbert S Huang; Craig Kollman; Aaron J Kowalski; Lori Laffel; Jean M Lawrence; Joyce Lee; Nelly Mauras; Michael O'Grady; Katrina J Ruedy; Michael Tansey; Eva Tsalikian; Stuart Weinzimer; Darrell M Wilson; Howard Wolpert; Tim Wysocki; Dongyuan Xing Journal: N Engl J Med Date: 2008-09-08 Impact factor: 91.245
Authors: Satish K Garg; James Smith; Christie Beatson; Benita Lopez-Baca; Mary Voelmle; Peter A Gottlieb Journal: Diabetes Technol Ther Date: 2009-02 Impact factor: 6.118
Authors: Ruth S Weinstock; Suzan Bristol; Andrew Armenia; A Chris Gesswein; B Wayne Bequette; John P Willis Journal: J Diabetes Sci Technol Date: 2012-11-01
Authors: Cornelis A J van Beers; Susanne J Kleijer; Erik H Serné; Petronella H Geelhoed-Duijvestijn; Frank J Snoek; Mark H H Kramer; Michaela Diamant Journal: BMC Endocr Disord Date: 2015-08-21 Impact factor: 2.763
Authors: Sam N Scott; Lorraine Anderson; James P Morton; Anton J M Wagenmakers; Michael C Riddell Journal: Nutrients Date: 2019-05-07 Impact factor: 5.717
Authors: Sarah Puhr; Mark Derdzinski; John B Welsh; Andrew Scott Parker; Tomas Walker; David A Price Journal: Diabetes Technol Ther Date: 2019-03-22 Impact factor: 6.118